22 results
8-K
EX-1.1
APLS
Apellis Pharmaceuticals Inc
1 Nov 23
Entry into a Material Definitive Agreement
7:59am
and/or principal in connection with the purchase and sale of the Company’s securities and not as a fiduciary of the Company and (c) the Company’s engagement
8-K
EX-1.1
wshl4ev8
24 Mar 22
Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
8:18pm
8-K
EX-1.1
f3pcd81kym6
20 Jan 22
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-1.1
ucjyezxn61l34qsje7e
17 Nov 21
Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
9:04am
8-K
EX-1.1
j4xs3vtc97qf6zlw
9 Jan 20
Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
5:22pm
POS AM
EX-1.2
7nfuyzngz
4 Oct 19
Prospectus update (post-effective amendment)
4:59pm
8-K
EX-1.1
bk563a7wm738
7 Mar 19
Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
4:15pm
S-3ASR
EX-1.2
1i8s23 hp1u1cn0a
28 Dec 18
Automatic shelf registration
4:37pm